US health agency issues low-level travel advisory for Andes virus in Argentina and Chile
The Centers for Disease Control and Prevention has classified the risk for Andes virus in Argentina and Chile as Level 1, urging standard hygiene measures rather than travel restrictions.
The US Centers for Disease Control and Prevention has issued a Level 1 travel health notice concerning Andes virus, a species of hantavirus found in South America. The advisory specifically targets Argentina and Chile, regions where the virus is naturally present and endemic.
Under the CDC’s travel health notice system, Level 1 is the lowest tier of alert. It indicates that travellers should practice usual precautions, reflecting a minimal immediate risk to the general public. This designation suggests that standard hygiene and safety measures are sufficient for most visitors, rather than requiring special protective equipment or avoidance of specific areas.
Andes virus is transmitted by certain rodents native to the region. The agency’s guidance does not specify the exact species of rodent responsible for carrying the virus, nor does it provide current data on the incidence rate or number of human cases in Argentina and Chile. The notice serves as standard public health guidance from a US federal agency and does not necessarily indicate a current outbreak or a spike in infections within the affected countries.
Public health officials distinguish Andes virus from other hantavirus strains prevalent in different geographic regions. For instance, it is distinct from the Sin Nombre virus, which is commonly found in North America. Maintaining this distinction is important for accurate risk assessment and understanding the specific biological context of the virus in South America.
The advisory reinforces the importance of general awareness for travellers visiting endemic zones. While the risk is categorised as low, the presence of the virus in the local rodent population means that standard precautions remain relevant. The CDC’s notice provides a framework for travellers to remain informed without causing unnecessary alarm.
As with all travel health notices, this guidance reflects the assessment of US public health authorities. Local healthcare capacity and specific regional conditions within Argentina and Chile may vary, and travellers are encouraged to stay updated on any further developments from both US and local health agencies.
